Literature DB >> 16220992

Mechanisms of cytotoxicity of selected organogold(III) compounds.

Marcella Coronnello1, Enrico Mini, Barbara Caciagli, Maria Agostina Cinellu, Alberto Bindoli, Chiara Gabbiani, Luigi Messori.   

Abstract

The effects of a few cytotoxic organogold(III) compounds on ovarian A2780 human cancer cells were investigated in comparison to cisplatin and oxaliplatin. The tested compounds produced significant antiproliferative effects and promoted apoptosis to a greater extent than platinum drugs while causing only modest cell cycle modifications. The mechanistic implications of these findings are discussed: mitochondrial pathways are proposed to be directly involved in the apoptotic process in relation to selective inhibition of thioredoxin reductase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16220992     DOI: 10.1021/jm050493o

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  18 in total

1.  Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study.

Authors:  Francesca Magherini; Alessandra Modesti; Luca Bini; Michele Puglia; Ida Landini; Stefania Nobili; Enrico Mini; Maria Agostina Cinellu; Chiara Gabbiani; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2010-01-29       Impact factor: 3.358

Review 2.  Thiol chemistry in peroxidase catalysis and redox signaling.

Authors:  Alberto Bindoli; Jon M Fukuto; Henry Jay Forman
Journal:  Antioxid Redox Signal       Date:  2008-09       Impact factor: 8.401

3.  Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regeneration.

Authors:  MaryClare F Rollins; Dana M van der Heide; Carla M Weisend; Jean A Kundert; Kristin M Comstock; Elena S Suvorova; Mario R Capecchi; Gary F Merrill; Edward E Schmidt
Journal:  J Cell Sci       Date:  2010-06-22       Impact factor: 5.285

4.  Synthesis, characterization, and in vitro antitumor properties of gold(III) compounds with the traditional Chinese medicine (TCM) active ingredient liriodenine.

Authors:  Zhen-Feng Chen; Yan-Cheng Liu; Yan Peng; Xue Hong; Hong-Hong Wang; Min-Min Zhang; Hong Liang
Journal:  J Biol Inorg Chem       Date:  2011-09-30       Impact factor: 3.358

5.  The gold (III) porphyrin complex, gold-2a, suppresses WNT1 expression in breast cancer cells by enhancing the promoter association of YY1.

Authors:  Kim Hei-Man Chow; Jing Liu; Raymond Wai-Yin Sun; Paul M Vanhoutte; Aimin Xu; Jie Chen; Chi-Ming Che; Yu Wang
Journal:  Am J Transl Res       Date:  2011-10-13       Impact factor: 4.060

6.  DNA binding properties of novel cytotoxic gold(III) complexes of terpyridine ligands: the impact of steric and electrostatic effects.

Authors:  Pengfei Shi; Qin Jiang; Yongmei Zhao; Yangmiao Zhang; Jun Lin; Liping Lin; Jian Ding; Zijian Guo
Journal:  J Biol Inorg Chem       Date:  2006-06-09       Impact factor: 3.358

7.  DNA interactions and photocatalytic strand cleavage by artificial nucleases based on water-soluble gold(III) porphyrins.

Authors:  Martin Haeubl; Lorenz Michael Reith; Bernadette Gruber; Uwe Karner; Norbert Müller; Günther Knör; Wolfgang Schoefberger
Journal:  J Biol Inorg Chem       Date:  2009-05-27       Impact factor: 3.358

8.  Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study.

Authors:  Angela Casini; Gerhard Kelter; Chiara Gabbiani; Maria Agostina Cinellu; Giovanni Minghetti; Dolores Fregona; Heinz-Herbert Fiebig; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2009-06-20       Impact factor: 3.358

9.  Proteomic approaches in understanding action mechanisms of metal-based anticancer drugs.

Authors:  Ying Wang; Jen-Fu Chiu
Journal:  Met Based Drugs       Date:  2008

10.  Anticancer Activity and Apoptosis Induction of Gold(III) Complexes Containing 2,2'-Bipyridine-3,3'-dicarboxylic Acid and Dithiocarbamates.

Authors:  Ali Alhoshani; Adam A A Sulaiman; Homood M As Sobeai; Wajhul Qamar; Moureq Alotaibi; Khalid Alhazzani; Muhammad Monim-Ul-Mehboob; Saeed Ahmad; Anvarhusein A Isab
Journal:  Molecules       Date:  2021-06-29       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.